HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Loris De Cecco Selected Research

Injections

1/2021Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case Report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Loris De Cecco Research Topics

Disease

53Neoplasms (Cancer)
11/2022 - 09/2004
21Breast Neoplasms (Breast Cancer)
01/2022 - 06/2005
11Ovarian Neoplasms (Ovarian Cancer)
03/2021 - 10/2004
11Squamous Cell Carcinoma of Head and Neck
01/2021 - 04/2015
5Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 04/2015
5Ovarian Epithelial Carcinoma
01/2022 - 07/2015
5Carcinoma (Carcinomatosis)
01/2020 - 03/2010
5Carcinogenesis
12/2019 - 10/2004
3Melanoma (Melanoma, Malignant)
11/2022 - 06/2004
3Disease Progression
11/2022 - 12/2017
3Glioma (Gliomas)
06/2022 - 06/2014
3Hypoxia (Hypoxemia)
01/2022 - 04/2015
3Squamous Cell Neoplasms (Squamous Cell Cancer)
12/2019 - 01/2016
2Infections
03/2021 - 01/2021
2Neoplasm Metastasis (Metastasis)
04/2020 - 01/2017
2Adenocarcinoma of Lung
10/2019 - 06/2009
2Sarcoma (Soft Tissue Sarcoma)
11/2018 - 01/2017
2Colonic Neoplasms (Colon Cancer)
01/2016 - 01/2012
2Colorectal Neoplasms (Colorectal Cancer)
01/2016 - 01/2013
1Circulating Neoplastic Cells
01/2022
1Triple Negative Breast Neoplasms
01/2022
1Breast Diseases (Breast Disease)
08/2021
1Rheumatoid Arthritis
06/2021
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/2021
1Pathologic Complete Response
01/2021
1Progressive Multifocal Leukoencephalopathy
01/2021
1Renal Cell Carcinoma (Grawitz Tumor)
01/2021
1Virus Diseases (Viral Diseases)
01/2021
1Diarrhea
01/2021
1Papillary Thyroid Cancer
11/2020
1Lymphatic Metastasis
11/2020
1Multiple Myeloma
10/2020

Drug/Important Bio-Agent (IBA)

25MicroRNAs (MicroRNA)IBA
01/2022 - 03/2010
10Biomarkers (Surrogate Marker)IBA
04/2021 - 11/2009
9Biological ProductsIBA
06/2022 - 10/2004
8Estrogen ReceptorsIBA
01/2020 - 06/2005
7Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2014
5RNA (Ribonucleic Acid)IBA
01/2022 - 06/2004
5Cetuximab (Erbitux)FDA Link
12/2019 - 01/2016
5PlatinumIBA
12/2019 - 01/2013
4Trastuzumab (Herceptin)FDA Link
01/2022 - 09/2015
4Pharmaceutical PreparationsIBA
01/2021 - 01/2016
4Complementary DNA (cDNA)IBA
06/2008 - 06/2004
3Phenobarbital (Luminal)FDA Link
01/2020 - 07/2015
3Urethane (Ethyl Carbamate)IBA
11/2017 - 04/2014
3Messenger RNA (mRNA)IBA
01/2017 - 01/2015
3Cisplatin (Platino)FDA LinkGeneric
07/2015 - 10/2011
3DNA (Deoxyribonucleic Acid)IBA
01/2013 - 10/2011
3CPG-oligonucleotideIBA
01/2013 - 10/2011
2VemurafenibIBA
11/2022 - 01/2016
2dipinacoline glutamateIBA
06/2022 - 06/2014
2Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2020 - 07/2015
2Long Noncoding RNAIBA
01/2020 - 01/2017
2Vinorelbine (Navelbine)FDA LinkGeneric
07/2018 - 06/2014
2nimotuzumabIBA
07/2018 - 06/2014
2Type 4 Fibroblast Growth Factor ReceptorIBA
06/2009 - 10/2004
2Estrogen Receptor Modulators (Antiestrogen)IBA
10/2008 - 06/2005
1Drug CombinationsIBA
11/2022
1Mechanistic Target of Rapamycin Complex 1IBA
11/2022
1dabrafenibIBA
11/2022
1trametinibIBA
11/2022
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2022
1MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
11/2022
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2022
1Complement System Proteins (Complement)IBA
12/2021
1pristane (pristan)IBA
06/2021
1Viral RNAIBA
03/2021
1COVID-19 VaccinesIBA
03/2021
1Methionine (L-Methionine)FDA Link
01/2021
1Choline KinaseIBA
01/2021
1Choline (Choline Chloride)IBA
01/2021
1LigandsIBA
01/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
01/2021
1Vasopressins (Vasopressin)IBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1InterferonsIBA
01/2021
1NivolumabIBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1Granzymes (Granzyme)IBA
01/2021
1Alkylating AgentsIBA
10/2020
1Proteasome InhibitorsIBA
10/2020
1Immunomodulating AgentsIBA
10/2020
1Tumor Biomarkers (Tumor Markers)IBA
04/2020
1Untranslated RNA (Noncoding RNA)IBA
01/2020
1Formaldehyde (Formol)FDA Link
01/2020
1ParaffinIBA
01/2020
1Piwi-Interacting RNAIBA
01/2020
1matrigelIBA
01/2020
1Transforming Growth Factor beta (TGF-beta)IBA
01/2020
1SmokeIBA
10/2019

Therapy/Procedure

19Therapeutics
11/2022 - 10/2008
10Drug Therapy (Chemotherapy)
10/2020 - 10/2011
4Neoadjuvant Therapy
01/2022 - 01/2021
2Aftercare (After-Treatment)
01/2022 - 01/2021
2Immunotherapy
01/2021 - 01/2017
2Re-Irradiation
07/2018 - 06/2014
1Salvage Therapy
01/2022
1Injections
01/2021
1Immunomodulation
01/2021